Physician profile
Donald Hoffman
NPI 1396772059
$1,216.61
in general payments reported to CMS, 2019-2025
18 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $73.35 · 2021: $35.84 · 2022: $114 · 2023: $151 · 2024: $653 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.82 |
| Education | $148.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $234.63 | 2022-2025 | Ajovy |
| Lundbeck LLC | $183.06 | 2021-2024 | Vyepti |
| Eisai INC. | $177.22 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $167.21 | 2023-2024 | |
| Pfizer INC. | $104.68 | 2024-2025 | |
| Tanabe Pharma America, INC. | $97.63 | 2024 | |
| Abbvie INC. | $34.59 | 2023-2025 | |
| Sk Life Science, INC. | $33.07 | 2024 | |
| Medtronic, INC. | $26.08 | 2025 | Inceptiv |
| Bayer Healthcare Pharmaceuticals INC. | $24.81 | 2023 | |
| Amgen INC. | $23.05 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.66 | 2022 | |
| Exact Sciences Corporation | $17.57 | 2024 | Cologuard Collection Kit |
| Baudax Bio INC. | $16.86 | 2020 | |
| Allergan, INC. | $16.01 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $14.81 | 2020 | |
| Sunovion Pharmaceuticals INC. | $12.87 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.